Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure

References

• Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011 Apr;7(4):219–231.
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016 Oct;37(5):467–520.
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010 Jun 30;8:41.
   PubMed Web of Science ®Google Scholar
• Lo JC, Feigenbaum SL, Escobar GJ, et al. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care. 2006 Aug;29(8):1915–1917.
   PubMed Web of Science ®Google Scholar
• Yu HF, Chen HS, Rao DP, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016 Dec;95(51):e4863.
   PubMed Web of Science ®Google Scholar
• Ibáñez L, Oberfield SE, Witchel S, et al. An International consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88(6):371–395.
   PubMed Web of Science ®Google Scholar
• Jankowska K. Premature ovarian failure. Prz Menopauzalny. 2017 Jun;16(2):51–56.
   PubMedGoogle Scholar
• Ayesha JV, Goswami D. Premature ovarian failure: an association with autoimmune diseases. J Clin Diagn Res. 2016 Oct;10(10):QC10–QC12.
   PubMed Web of Science ®Google Scholar
• Brand JS, Onland-Moret NC, Eijkemans MJ, van der Schouw YT, et al. Diabetes and onset of natural menopause: results from the European prospective investigation into cancer and nutrition. Hum Reprod. 2015 Jun;30(6):1491–1498.
   PubMed Web of Science ®Google Scholar
• Isik H, Sahbaz A, Timur H, et al. The use of thiol/disulfide as a novel marker in premature ovarian failure. Gynecol Obstet Invest. 2017;82(2):113–118.
   PubMed Web of Science ®Google Scholar
• Nandagopal L, Sonpavde G. Circulating biomarkers in bladder cancer. Bladder Cancer. 2016 Oct 27;2(4):369–379.
   PubMed Web of Science ®Google Scholar
• Oberg K, Modlin IM, De Herer W, et al. Consensus on biomarkers for neuroendocrine tumour disease. Lancet Oncol. 2015 Sep;16(9):e435–e446.
   PubMed Web of Science ®Google Scholar
• Fan Y, Li Y, Chen Y, et al. Comprehensive metabolomic characterization of coronary artery diseases. J Am Coll Cardiol. 2016 Sep 20;68(12):1281–1293.
   PubMed Web of Science ®Google Scholar
• Mapstone M, Cheema AK, Fiandaca MS, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014 Apr;20(4):415–418.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang A, Sun H. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology. 2013 May;57(5):2072–2077.
   PubMed Web of Science ®Google Scholar
• Kimhofer T, Fye H, Taylor-Robinson S, et al. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015 Mar 31;112(7):1141–1156.
   PubMed Web of Science ®Google Scholar
• Liang Q, Liu H, Wang C, et al. Phenotypic characterization analysis of human hepatocarcinoma by urine metabolomics approach. Sci Rep. 2016 Jan 25;6:19763.
   PubMed Web of Science ®Google Scholar
• Omabe M, Elom S, Omabe KN. Emerging metabolomics biomarkers of polycystic ovarian syndrome; targeting the master metabolic disrupters for diagnosis and treatment. Endocr Metab Immune Disord Drug Targets. 2018;18(3):221–229.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang X, Cao X, et al. Serum biomarker analysis in patients with premature ovarian insufficiency. Cytokine. 2020 Feb;126:154876.
   PubMed Web of Science ®Google Scholar
• Rajska A, Buszewska-Forajta M, Rachoń D, et al. Metabolomic insight into polycystic ovary syndrome-an overview. Int J Mol Sci. 2020 Jul 9;21(14):4853.
   PubMed Web of Science ®Google Scholar
• Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006 Apr 6;1:9.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016 Aug 11;2:16057.
   PubMed Web of Science ®Google Scholar
• Murri M, Insenser M, Escobar-Morreale HF. Metabolomics in polycystic ovary syndrome. Clin Chim Acta. 2014 Feb 15;429:181–188.
   PubMed Web of Science ®Google Scholar
• Dunn WB, Broadhurst D, Begley P, et al. Human Serum Metabolome (HUSERMET) Consortium. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011 Jun 30;6(7):1060–1083.
   PubMed Web of Science ®Google Scholar
• Sun Z, Chang HM, Wang A, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reprod Biol Endocrinol. 2019 Jun 11;17(1):45.
   PubMedGoogle Scholar
• Ghahremani-Nasab M, Ghanbari E, Jahanbani Y, et al. Premature ovarian failure and tissue engineering. J Cell Physiol. 2020 May;235(5):4217–4226.
   PubMed Web of Science ®Google Scholar
• Arya BK, Haq AU, Chaudhury K. Oocyte quality reflected by follicular fluid analysis in poly cystic ovary syndrome (PCOS): a hypothesis based on intermediates of energy metabolism. Med Hypotheses. 2012 Apr;78(4):475–478.
   PubMed Web of Science ®Google Scholar
• Chang HM, Qiao J, Leung PC. Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors. Hum Reprod Update. 2016 Dec;23(1):1–18.
   PubMed Web of Science ®Google Scholar
• Niu Z, Lin N, Gu R, et al. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab. 2014 Nov;99(11):E2269–76.
   PubMed Web of Science ®Google Scholar
• Pirwany IR, Fleming R, Greer IA, et al. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf). 2001 Apr;54(4):447–453.
   PubMed Web of Science ®Google Scholar
• Ducker GS, Rabinowitz JD. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017 Jan 10;25(1):27–42.
   PubMed Web of Science ®Google Scholar
• Schalinske KL, Smazal AL. Homocysteine imbalance: a pathological metabolic marker. Adv Nutr. 2012 Nov 1;3(6):755–762.
   PubMed Web of Science ®Google Scholar
• Li D, Liu HX, Fang YY, et al. Hyperhomocysteinemia in polycystic ovary syndrome: decreased betaine-homocysteine methyltransferase and cystathionine β-synthase-mediated homocysteine metabolism. Reprod Biomed Online. 2018 Aug;37(2):234–241.
   PubMed Web of Science ®Google Scholar
• Hou N, Chen S, Chen F, et al. Association between premature ovarian failure, polymorphisms in MTHFR and MTRR genes and serum homocysteine concentration. Reprod Biomed Online. 2016 Apr;32(4):407–413.
   PubMed Web of Science ®Google Scholar
• PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem Compound Summary for CID 5862, Cysteine; [cited 2021 Jul 25]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Cysteine
   Google Scholar
• PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem Compound Summary for CID 6337958, N-Acetyldemethylphosphinothricin; [cited 2021 Jul 25]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/N-Acetyldemethylphosphinothricin
   Google Scholar
• PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem Compound Summary for CID 6412, Methyl sulfate; [cited 2021 Jul 25]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Methyl-sulfate
   Google Scholar
• Szczuko M, Hawryłkowicz V, Kikut J, et al. The implications of vitamin content in the plasma in reference to the parameters of carbohydrate metabolism and hormone and lipid profiles in PCOS. J Steroid Biochem Mol Biol. 2020 Apr;198:105570.
   PubMed Web of Science ®Google Scholar
• PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem Compound Summary for CID 135, 4-Hydroxybenzoic acid; [cited 2021 Jul 25]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/4-Hydroxybenzoic-acid
   Google Scholar
• Troisi J, Cinque C, Giugliano L, et al. Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study. J Ovarian Res. 2019 Mar 23;12(1):25.
   PubMedGoogle Scholar
• Vantaku V, Donepudi SR, Piyarathna DWB, et al. Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival. Cancer. 2019 Mar 15;125(6):921–932.
   PubMed Web of Science ®Google Scholar
• Luo P, Yin P, Hua R, et al. multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018 Feb;67(2):662–675.
   PubMed Web of Science ®Google Scholar
• Blanchard V, Garçon D, Jaunet C, et al. A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins. J Lipid Res. 2020 Jul;61(7):1128–1139.
   PubMed Web of Science ®Google Scholar
• Lee DH, Pei CZ, Song JY, et al. Identification of serum biomarkers for premature ovarian failure. Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):219–226.
   PubMed Web of Science ®Google Scholar